MASTERINVEST Kapitalanlage GmbH acquired a new position in Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, HoldingsChannel.com reports. The firm acquired 14,233 shares of the conglomerate’s stock, valued at approximately $2,711,000.
A number of other hedge funds have also recently made changes to their positions in the stock. BlackRock Inc. purchased a new stake in Danaher in the second quarter valued at approximately $10,492,520,000. Norges Bank acquired a new position in Danaher during the fourth quarter worth $2,177,106,000. Jupiter Topco LLC purchased a new position in shares of Danaher during the second quarter worth $1,456,317,000. Generation Investment Management LLP purchased a new position in shares of Danaher during the second quarter worth $1,287,949,000. Finally, Bank of America Corp DE acquired a new stake in shares of Danaher in the second quarter valued at $993,846,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Price Performance
Shares of NYSE DHR opened at $215.74 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The company has a market cap of $151.67 billion, a price-to-earnings ratio of 38.32, a price-to-earnings-growth ratio of 2.68 and a beta of 0.78. The stock’s 50-day moving average is $198.69 and its two-hundred day moving average is $192.35. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.
Wall Street Analysts Forecast Growth
DHR has been the topic of several research analyst reports. Piper Sandler assumed coverage on Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price objective on the stock. HSBC lowered their target price on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Stifel Nicolaus dropped their target price on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Wells Fargo & Company cut their price target on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Finally, DZ Bank began coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.
View Our Latest Analysis on Danaher
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
